Goat anti-ADRB1
EB07133
ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
Product group Antibodies
TargetADRB1
Overview
- SupplierEverest Biotech
- Product NameGoat anti-ADRB1 Antibody
- Delivery Days Customer5
- Application Supplier NoteImmunofluorescence: Strong expression of the protein seen in the plama membrane and cytoplasm of HeLa cells. Recommended concentration: 10microg/ml.
- ApplicationsImmunoFluorescence, ELISA, ImmunoHistoChemistry
- Applications SupplierPep-ELISA, IHC, IF
- CertificationResearch Use Only
- ClonalityPolyclonal
- Concentration0.5 mg/ml
- Gene ID153
- Target nameADRB1
- Target descriptionadrenoceptor beta 1
- Target synonymsADRB1R, B1AR, BETA1AR, FNSS2, RHR, beta-1 adrenergic receptor, adrenergic, beta-1-, receptor, beta-1 adrenoceptor, beta-1 adrenoreceptor
- HostGoat
- Scientific DescriptionRefSeq number(s): NP_000675.1. Purification: Antigen affinity purified. Names and symbols: ADRB1; adrenergic, beta-1-, receptor; ADRB1R; B1AR; BETA1AR; RHR; beta-1-adrenergic receptor
- Reactivity SupplierHuman, Mouse, Rat, Dog
- Storage Instruction-20°C
- UNSPSC12352203
References
- Wallukat G, Prüss H, Müller J, et al. Functional autoantibodies in patients with different forms of dementia. PLoS One. 2018,13(3):e0192778. doi: 10.1371/journal.pone.0192778Read this paper
- Wenzel K, Schulze-Rothe S, Müller J, et al. Difference between beta1-adrenoceptor autoantibodies of human and animal origin-Limitations detecting beta1-adrenoceptor autoantibodies using peptide based ELISA technology. PLoS One. 2018,13(2):e0192615. doi: 10.1371/journal.pone.0192615Read this paper
- Wenzel K, Schulze-Rothe S, Haberland A, et al. Performance and in-house validation of a bioassay for the determination of beta1-autoantibodies found in patients with cardiomyopathy. Heliyon. 2017,3(7):e00362. doi: 10.1016/j.heliyon.2017.e00362Read this paper
- Wallukat G, Haberland A, Berg S, et al. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies. Circ J. 2012,76(10):2449-55.Read this paper
- Haberland A, Wallukat G, Dahmen C, et al. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies. Circ Res. 2011,109(9):986-92. doi: 10.1161/CIRCRESAHA.111.253849Read this paper
- Wallukat G, Muñoz Saravia SG, Haberland A, et al. Distinct patterns of autoantibodies against G-protein-coupled receptors in Chagas' cardiomyopathy and megacolon. Their potential impact for early risk assessment in asymptomatic Chagas' patients. J Am Coll Cardiol. 2010,55(5):463-8. doi: 10.1016/j.jacc.2009.06.064Read this paper





